Muhammad Zohaib Khan (2024) “FREQUENCY OF END OF TREATMENT RESPONSE IN GENOTYPE 3 CIRRHOTIC PATIENTS TAKING SOFOSBUVIR, RIBAVIRIN AND DACLATASVIR”, Journal of Population Therapeutics and Clinical Pharmacology, 31(9), pp. 4104–4128. doi:10.53555/vgped651.